Dysregulated Gene Expression in Lymphoblasts from Parkinson's Disease
Sarah Jane Annesley1, Claire Yvonne Allan1, Oana Sanislav1
1Department of Microbiology, Anatomy, Physiology and Pharmacology, La Trobe University, Melbourne, VIC 3086, Australia.
Proteomes
|June 23, 2022
Summary
Parkinson's disease (PD) involves widespread cellular changes, including altered protein synthesis and immune responses. This study found discrepancies between mRNA and protein levels in PD cells, particularly in mitochondrial function.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Parkinson's disease (PD) is a major neurodegenerative disorder impacting multiple tissues, not just the brain.
- Investigating accessible tissues like blood and skin aids understanding of PD pathogenesis.
Purpose of the Study:
- To analyze transcriptomic and proteomic changes in lymphoblast cell lines from Parkinson's disease patients compared to controls.
- To identify molecular alterations in Parkinson's disease using integrated multi-omics data.
Main Methods:
- Generated whole-cell transcriptomes and proteomes from lymphoblast cell lines of Parkinson's disease patients and healthy controls.
- Performed comparative analysis of gene and protein expression patterns.
Main Results:
- Observed global downregulation of protein synthesis genes and upregulation of immune processes and sphingolipid metabolism in Parkinson's disease cells.
- Identified an uncoupling of mRNA and protein expression for mitochondrial respiration, with downregulated transcripts and upregulated proteins.
- Noted unique regulation for Complex V, showing lower transcripts and non-elevated polypeptide levels.
Conclusions:
- Parkinson's disease exhibits complex molecular dysregulation across multiple cellular pathways beyond the central nervous system.
- Discrepancies in mRNA and protein levels suggest post-transcriptional regulatory mechanisms are critical in Parkinson's disease.
- Complex V may involve distinct regulatory layers contributing to mitochondrial dysfunction in Parkinson's disease.
Keywords:
Parkinson’s diseasecell modelsmitochondriaoxidative phosphorylationprotein synthesisproteometranscriptomeMore Related Videos
Related Concept Videos
01:37Neural Regulation
39.8K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.8K
01:15Parkinson's Disease: Overview
700
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
700
01:22Lysosomal Hydrolases
3.9K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.9K
01:24Parkinson's Disease: Treatment
371
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
371
02:23Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
01:21EPS and iPS Cells in Disease Research
2.9K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.9K